Cargando…

Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis

Nanotechnology could improve our understanding of the pathophysiology of atherosclerosis and contribute to the development of novel diagnostic and therapeutic strategies to further reduce the risk of cardiovascular disease. Macrophages have key roles in atherosclerosis progression and, therefore, ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Wei, Schilperoort, Maaike, Cao, Yihai, Shi, Jinjun, Tabas, Ira, Tao, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580169/ https://www.ncbi.nlm.nih.gov/pubmed/34759324 http://dx.doi.org/10.1038/s41569-021-00629-x

Ejemplares similares

Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
por: Hu, Ping Ping, et al.
Publicado: (2022)

Immunomodulatory Nanomedicine for the Treatment of Atherosclerosis
por: Peters, Linsey J. F., et al.
Publicado: (2021)

Biomimetic nanomedicines for precise atherosclerosis theranostics
por: Tao, Ying, et al.
Publicado: (2023)

Recent insights into the cellular biology of atherosclerosis
por: Tabas, Ira, et al.
Publicado: (2015)

Editorial: Advances on targeted nanomedicines for atherosclerosis
por: Han, Qinggong, et al.
Publicado: (2022)

Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective
por: Nakhlband, Ailar, et al.
Publicado: (2018)

Nanomedicine Strategies to Target Tumor-Associated Macrophages
por: Binnemars-Postma, Karin, et al.
Publicado: (2017)

Macrophage-Targeted Nanomedicines for ARDS/ALI: Promise and Potential
por: Vichare, Riddhi, et al.
Publicado: (2022)

Role of macrophage in nanomedicine-based disease treatment
por: Song, Siwei, et al.
Publicado: (2021)

Exploiting targeted nanomedicine for surveillance, diagnosis, and treatment of hepatocellular carcinoma
por: Liu, Tingting, et al.
Publicado: (2023)

Macrophage Targeted Theranostics as Personalized Nanomedicine Strategies for Inflammatory Diseases
por: Patel, Sravan Kumar, et al.
Publicado: (2015)

Biomedical applications of mRNA nanomedicine
por: Xiong, Qingqing, et al.
Publicado: (2018)

Stimulus-Responsive Nanomedicines for Disease Diagnosis and Treatment
por: Liu, Gengqi, et al.
Publicado: (2020)

Nanomedicine engulfed by macrophages for targeted tumor therapy
por: Li, Siwen, et al.
Publicado: (2016)

Nanomaterials as Promising Theranostic Tools in Nanomedicine and Their Applications in Clinical Disease Diagnosis and Treatment
por: Zhu, Wei, et al.
Publicado: (2021)

Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis
por: Yurdagul, Arif, et al.
Publicado: (2018)

Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy
por: Wu, Ping-Hsiu, et al.
Publicado: (2019)

Ferritin-based nanomedicine for disease treatment
por: Zhu, Yuanjun, et al.
Publicado: (2023)

Development of functional nanomedicines for tumor associated macrophages-focused cancer immunotherapy
por: Wei, Xiao, et al.
Publicado: (2022)

Insights into Nanomedicine for Head and Neck Cancer Diagnosis and Treatment
por: Viegas, Cláudia, et al.
Publicado: (2022)

Tuning macrophages for atherosclerosis treatment
por: Fang, Fei, et al.
Publicado: (2022)

Nanomedicine in cancer therapy
por: Fan, Dahua, et al.
Publicado: (2023)

Targeted Delivery of Nanomedicines
por: Kumar Khanna, Vinod
Publicado: (2012)

A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease
por: Rani, Alankrita, et al.
Publicado: (2023)

Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications
por: Li, Xue, et al.
Publicado: (2022)

Recent advances in nanomedicines for the treatment of ischemic stroke
por: Li, Chao, et al.
Publicado: (2021)

Macrophage MicroRNAs as Therapeutic Targets for Atherosclerosis, Metabolic Syndrome, and Cancer
por: Wei, Yuanyuan, et al.
Publicado: (2018)

State-of-the-Art Advances of Nanomedicine for Diagnosis and Treatment of Bladder Cancer
por: Kong, Chenfan, et al.
Publicado: (2022)

Recent advances in nanomedicines for regulation of macrophages in wound healing
por: Joorabloo, Alireza, et al.
Publicado: (2022)

Current research trends of nanomedicines
por: Liu, Qiuyue, et al.
Publicado: (2023)

Advances of Nanomedicine in Radiotherapy
por: Liu, Wei, et al.
Publicado: (2021)

Targeted Photodynamic Diagnosis and Therapy for Esophageal Cancer: Potential Role of Functionalized Nanomedicine
por: Didamson, Onyisi Christiana, et al.
Publicado: (2021)

Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19
por: Vahedifard, Farzan, et al.
Publicado: (2021)

Recent Advances in Nanomedicine for the Diagnosis and Treatment of Prostate Cancer Bone Metastasis
por: Hagaman, Daniel E., et al.
Publicado: (2021)

Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma
por: Ladju, Rusdina Bte, et al.
Publicado: (2017)

The Use of Nanomedicine to Target Signaling by the PAK Kinases for Disease Treatment
por: Wang, Yiling, et al.
Publicado: (2021)

Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol
por: Barnes, Theresa, et al.
Publicado: (2007)

Current Nanomedicine for Targeted Vascular Disease Treatment: Trends and Perspectives
por: Choi, Kyung-A, et al.
Publicado: (2022)

Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system
por: Xie, Fang-Yuan, et al.
Publicado: (2016)

Trophoblast-Targeted Nanomedicine Modulates Placental sFLT1 for Preeclampsia Treatment
por: Li, Lei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e743dahvbvjqj9beon6hppkj5g